Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 89.95%23.27M | 84.72%50.9M | -17.08%3.23M | 671.41%37.48M | -112.24%-2.07M | 561.50%12.25M | 170.47%27.55M | 3.9M | 4.86M | 16.94M |
| Net profit before non-cash adjustment | 47.32%6.87M | 26.24%37.09M | -34.65%11.19M | 953.88%13.22M | 43.09%8.01M | -43.13%4.67M | 122.68%29.38M | --17.12M | ---1.55M | --5.6M |
| Total adjustment of non-cash items | -178.33%-334K | -121.97%-1.73M | -115.60%-1.2M | -239.67%-411K | -98.80%1K | -153.81%-120K | 668.61%7.87M | --7.69M | ---121K | --83K |
| -Depreciation and amortization | 11.98%215K | 19.08%892.11K | -19.34%196.11K | 30.61%256K | 68.71%248K | 17.79%192K | 25.37%749.14K | --243.14K | --196K | --147K |
| -Reversal of impairment losses recognized in profit and loss | ---- | -114.73%-1.18M | -114.77%-1.18M | ---- | ---- | ---- | 2,039.34%7.99M | --7.99M | ---- | ---- |
| -Disposal profit | ---- | 88.15%-28.61K | 100.16%387 | --0 | ---- | ---- | 17.74%-241.36K | ---237.36K | --0 | ---- |
| -Net exchange gains and losses | ---- | ---42.69K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Other non-cash items | -75.96%-549K | -118.36%-1.37M | 44.57%-172.77K | ---670K | ---218K | -620.00%-312K | -288.45%-628.67K | ---311.67K | ---- | ---- |
| Changes in working capital | 117.14%16.73M | 260.25%15.54M | 67.69%-6.76M | 278.00%24.68M | -189.59%-10.09M | 217.17%7.71M | -140.60%-9.7M | ---20.91M | --6.53M | --11.26M |
| -Change in receivables | 30.10%29.43M | 73.78%-15.19M | -0.67%-23.79M | 96.33%-267K | -63.80%-13.76M | 221.45%22.62M | -11,729.20%-57.94M | ---23.64M | ---7.28M | ---8.4M |
| -Change in payables | 2.97%-18.66M | -52.37%23M | 276.12%13.19M | 100.29%25.94M | -84.23%3.11M | -258.88%-19.23M | 1,498.52%48.29M | --3.51M | --12.95M | --19.73M |
| -Changes in other current assets | 38.13%5.96M | 15,091.06%7.73M | 595.31%3.85M | -216.74%-997K | 844.00%558K | 8,239.62%4.31M | 40.67%-51.54K | ---777.54K | --854K | ---75K |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | 44.44%-20K | 4.37%-225.69K | -80.17%-102.69K | -33.33%-48K | 45.83%-39K | 49.30%-36K | 24.36%-235.99K | -56.99K | -36K | -72K |
| Interest received (cash flow from operating activities) | 136.31%423K | 41.59%933.83K | -415.78%-393.17K | 122.80%811K | 130.82%337K | 616.00%179K | 1,641.19%659.51K | 124.51K | 364K | 146K |
| Tax refund paid | -134.40%-4.77M | -98.75%-13.11M | -92.80%-6.38M | -86.79%-3.05M | -98.42%-1.64M | -146.67%-2.04M | -89.91%-6.59M | -3.31M | -1.64M | -825K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 82.49%18.9M | 80.04%38.5M | -653.51%-3.64M | 890.77%35.19M | -121.07%-3.41M | 955.96%10.36M | 232.00%21.38M | --658.12K | --3.55M | --16.19M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | -93.75%-31K | -178.04%-499.5K | -239.42%-283.5K | -22.44%-191K | 94.61%-9K | 73.33%-16K | 47.94%-179.65K | --203.35K | ---156K | ---167K |
| Net investment product transactions | ---- | 57.46%-1.08M | 93.64%-160.95K | -820.47%-915K | ---- | ---- | -8,753.18%-2.53M | ---2.53M | --127K | ---- |
| Advance cash and loans provided to other parties | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Dividends received (cash flow from investment activities) | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net changes in other investments | 93.91%-33K | ---- | ---- | ---- | 67.49%-304K | 60.29%-542K | ---- | ---- | --0 | ---935K |
| Investing cash flow | 88.53%-64K | 41.84%-1.58M | -1,626.89%-444.45K | -796.55%-260K | 74.53%-313K | 60.84%-558K | -533.86%-2.71M | ---25.74K | ---29K | ---1.23M |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 81.45%-23K | 142.01%153.84K | -32.29%129.84K | 30.43%-1.82M | 1,140.25%1.97M | -106.51%-124K | -222.23%-366.24K | --191.76K | ---2.62M | --159K |
| Net common stock issuance | ---- | --0 | --0 | --0 | ---- | ---- | 26,021,700.00%26.02M | --800 | --0 | ---- |
| Increase or decrease of lease financing | -14.16%-129K | -24.04%-656.38K | 6.94%-131.38K | 35.10%-135K | -264.47%-277K | -8.65%-113K | -31.84%-529.18K | ---141.18K | ---208K | ---76K |
| Issuance fees | ---- | --0 | ---- | ---- | ---- | ---- | ---1.3M | ---- | ---- | ---- |
| Cash dividends paid | ---- | ---4.83M | --358 | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Financing cash flow | 35.86%-152K | -122.39%-5.34M | 99.91%-1.18K | 30.78%-1.96M | -112.02%-3.14M | -113.16%-237K | 629.22%23.82M | ---1.25M | ---2.83M | --26.1M |
| Net cash flow | ||||||||||
| Beginning cash position | 62.60%82.15M | 529.59%50.52M | 68.55%86.2M | 5.50%53.22M | 540.44%60.09M | 529.56%50.52M | 46.59%8.02M | --51.14M | --50.45M | --9.38M |
| Current changes in cash | 95.40%18.69M | -25.68%31.59M | -560.59%-4.09M | 4,658.01%32.97M | -116.71%-6.86M | 604.79%9.56M | 1,558.03%42.5M | ---618.9K | --693K | --41.07M |
| Effect of exchange rate changes | ---- | --42.69K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| End cash Position | 67.82%100.84M | 62.60%82.15M | 62.60%82.15M | 68.55%86.2M | 5.50%53.22M | 540.44%60.09M | 529.59%50.52M | --50.52M | --51.14M | --50.45M |
| Free cash flow | 82.47%18.87M | 81.15%37.78M | -858.01%-3.93M | 930.65%35M | -122.73%-3.64M | 1,023.02%10.34M | 242.13%20.85M | --517.97K | --3.4M | --16.02M |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.